# Gérard M. London

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gerard-m-london/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,607 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 100 |
| i10-index | 287 |
| OpenAlex ID | https://openalex.org/A5041217068 |
| ORCID iD | https://orcid.org/0000-0002-1059-600X |
| Works | 465 |

## Researcher papers

- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement](https://scholariq.org/papers/kidney-disease-improving-global-outcomes-guidelines-on-anaemia-management-in/)
- [Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure](https://scholariq.org/papers/epidemiology-contributors-to-and-clinical-trials-of-mortality-risk-in-chronic/)
- [Vascular calcification in chronic kidney disease](https://scholariq.org/papers/vascular-calcification-in-chronic-kidney-disease/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)
- [Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*](https://scholariq.org/papers/hypertension-in-dialysis-patients-a-consensus-document-by-the-european-renal-and/)
- [SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA](https://scholariq.org/papers/sglt-2-inhibitors-and-glp-1-receptor-agonists-for-nephroprotection-and/)
- [Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study](https://scholariq.org/papers/improvement-of-mineral-and-bone-metabolism-markers-is-associated-with-better/)
- [Blood pressure in chronic kidney disease stage 5D—report from a Kidney Disease: Improving Global Outcomes controversies conference](https://scholariq.org/papers/blood-pressure-in-chronic-kidney-disease-stage-5d-report-from-a-kidney-disease/)
- [Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-valvular-heart-disease-conclusions-from-a-kidney/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Heart Rate Variability and Autonomic Control](https://scholariq.org/topics/heart-rate-variability-and-autonomic-control/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.